Company intelligence / Profile preview

Chesson Labs

Durham, North Carolina, United Stateschessonlabs.com ↗

Ownership: Private
Development stage: Commercial

Overview

Chesson Labs has developed a patented polymer-based liquid bandage that is FDA 510(k) cleared. The product has demonstrated biocompatibility and effectiveness as a barrier to bacteria in bench testing. It is marketed for use in wound care, including post-surgical wounds, burns, bites/stings, and nail dystrophy. All lots have met performance specifications in regulatory submissions.

Therapeutic areas: Dermatology
Modalities: DevicePolymer-based medical product (specifically, polymer-based liquid bandage and wound care products)
Industry: Consumable Medical Devices

Drug pipeline

3 assets

NUVADERM First Aid

Commercial

Indications: Wound care

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Chesson Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chesson Labs.

Explore the full profile